Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorLazarus, Jeffrey V.
dc.contributor.authorMiralles-Sanchez, Juan Emilio
dc.contributor.authorAgirre Garrido, Leire
dc.contributor.authorBrachowicz, Nicolai
dc.contributor.authorNicolàs Olivé, Aina
dc.contributor.authorArmenta, Anthony
dc.contributor.authorPericas, Juan M
dc.date.accessioned2025-04-29T11:13:20Z
dc.date.available2025-04-29T11:13:20Z
dc.date.issued2025-05
dc.identifier.citationLazarus JV, Miralles-Sanchez JE, Agirre-Garrido L, Brachowicz N, Nicolàs A, Anthony JR, et al. A call to action to address the steatotic liver disease public health threat in Barcelona. Lancet Reg Heal - Eur. 2025 May;52:101272.
dc.identifier.issn2666-7762
dc.identifier.urihttp://hdl.handle.net/11351/13010
dc.descriptionCity health; Health policy; Liver disease
dc.description.abstractDespite their high prevalence worldwide, steatotic liver diseases (SLDs) are largely excluded from most non-communicable disease (NCD) guidelines and strategies. We propose policies and strategies to achieve the United Nations Sustainable Development Goal of reducing NCD premature mortality by one-third by 2030. To assess this gap—the exclusion of SLDs from NCD policies—in urban areas, we reviewed Barcelona’s strategies for NCD risks (e.g., alcohol, tobacco, healthy food access). We then explored applications of geo-spatial visualisation and whole-of-society approaches (e.g., citizen science engagement) aligned with the World Health Organization (WHO) Best Buys to provide recommendations to address NCDs, generally, and SLDs specifically.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesThe Lancet Regional Health - Europe;52
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectSalut urbana
dc.subjectPolítica sanitària
dc.subjectFetge - Malalties - Tractament
dc.subject.meshLiver Diseases
dc.subject.mesh/therapy
dc.subject.meshHealth Policy
dc.subject.meshUrban Health
dc.titleA call to action to address the steatotic liver disease public health threat in Barcelona
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.lanepe.2025.101272
dc.subject.decsenfermedades hepáticas
dc.subject.decs/terapia
dc.subject.decspolítica sanitaria
dc.subject.decssalud urbana
dc.relation.publishversionhttps://doi.org/10.1016/j.lanepe.2025.101272
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Lazarus JV] Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain. Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA. [Miralles-Sanchez JE, Agirre-Garrido L, Brachowicz N, Nicolàs A, Armenta A] Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain. [Pericàs JM] Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, CIBERehd, Barcelona, Spain. Johns Hopkins University-Pompeu Fabra University Public Policy Center, Barcelona, Spain
dc.identifier.pmid40207291
dc.identifier.wos001455597500001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record